|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pneumology (Drs. Tamm, Traenkle, Soler, and Bolliger), Department of Internal Medicine, and Institute of Pathology (Mr. Grilli and Drs. Dalquen and Cathomas), University Hospital Basel, Basel, Switzerland.
Correspondence to: Michael Tamm, MD, Division of Pneumology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland; e-mail: mtamm{at}uhbs.ch
Background: Cytomegalovirus (CMV) infection and CMV disease are frequent complications in immunocompromised patients. In this study, the incidence of pulmonary CMV infection was analyzed in different groups of immunocompromised patients and the diagnostic value of immunostaining with anti-CMV antibodies in BAL cells was evaluated in regard to the diagnosis of CMV pneumonitis.
Methods: Five hundred eighty consecutive BAL procedures were analyzed prospectively in 442 immunocompromised and 126 nonimmunocompromised control subjects. CMV culture in BAL fluid was performed by shell vial assay and immunostaining using three monoclonal anti-CMV antibodies.
Results: The incidence of culture results positive for CMV in the BAL fluid varied from 20 to 30% in HIV-positive patients, in patients following stem cell or renal transplantation, and in patients with autoimmune disease or lung fibrosis treated with immunosuppressive agents. CMV was cultured from 4.4% of BALs in patients treated with high-dose chemotherapy and from 2.4% of control subjects. CMV disease developed in 37 patients; in 18 of these patients, CMV pneumonitis was present. The results of CMV immunostaining were positive in a total of 22 BALs, all in patients with CMV disease. The sensitivity, specificity, and positive and negative predictive values of positive CMV immunostaining results for the diagnosis of CMV pneumonitis were 88.9%, 98.6%, 72.7%, and 99.5%, respectively.
Conclusion: The incidence of pulmonary CMV infection is similar in different groups of immunocompromised patients except for patients following high-dose chemotherapy. CMV immunostaining in the BAL fluid is a very helpful method to diagnose CMV pneumonitis in these patients.
Key Words: BAL cytomegalovirus infection cytomegalovirus immunostaining
This article has been cited by other articles:
![]() |
D. Stolz, A. Stulz, B. Muller, A. Gratwohl, and M. Tamm BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised Host Chest, August 1, 2007; 132(2): 504 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Franquet, S. Rodriguez, R. Martino, A. Gimenez, T. Salinas, and A. Hidalgo Thin-Section CT Findings in Hematopoietic Stem Cell Transplantation Recipients with Respiratory Virus Pneumonia Am. J. Roentgenol., October 1, 2006; 187(4): 1085 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Joos and M. Tamm Breakdown of Pulmonary Host Defense in the Immunocompromised Host: Cancer Chemotherapy Proceedings of the ATS, December 1, 2005; 2(5): 445 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tueller, P. N. Chhajed, C. Buitrago-Tellez, R. Frei, M. Frey, and M. Tamm Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis Eur. Respir. J., November 1, 2005; 26(5): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M W Beresford, A G Cleary, J A Sills, J Couriel, and J E Davidson Cardio-pulmonary involvement in juvenile systemic lupus erythematosus Lupus, February 1, 2005; 14(2): 152 - 158. [Abstract] [PDF] |
||||
![]() |
R. F. Chemaly, B. Yen-Lieberman, E. A. Castilla, A. Reilly, S. Arrigain, C. Farver, R. K. Avery, S. M. Gordon, and G. W. Procop Correlation between Viral Loads of Cytomegalovirus in Blood and Bronchoalveolar Lavage Specimens from Lung Transplant Recipients Determined by Histology and Immunohistochemistry J. Clin. Microbiol., May 1, 2004; 42(5): 2168 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-C. Chang, C.-L. Wu, S.-H. Pan, T.-Y. Yang, C.-S. Chin, Y.-C. Yang, and C.-D. Chiang The Diagnosis of Pneumonia in Renal Transplant Recipients Using Invasive and Noninvasive Procedures Chest, February 1, 2004; 125(2): 541 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
A T Jones, R M Du Bois, and A U Wells The pulmonary physician in critical care * Illustrative case 2: Interstitial lung disease Thorax, April 1, 2003; 58(4): 361 - 364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |